Get to know our clinical trials

Project of Genetic Prediction and Nutritional Intervention with Postbiotics modulators of the microbiota in patients with Type 2 diabetes.

THE MAIN OBJECTIVE OF THE PROJECT IS TO EVALUATE THE EFFECT OF POSTBIOTIC ADMINISTRATION ON GLYCEMIC CONTROL, INSULIN RESISTANCE AND MICROBIOTA COMPOSITION IN SUBJECTS WITH TYPE 2 DIABETES (DM2).

Imagen del Dr. Javier Escalada San Martin, especialista de Endocrinología de la Clínica Universidad de Navarra. El Dr. Escalada se dedica preferencialmente al diagnóstico y tratamiento de la diabetes mellitus, obesidad, enfermedad hepática esteatósica metabólica y osteoporosis y al estudio y tratamiento endocrinológico de tumores gastroenteropancreáticos.
Dr. Javier Escalada Curriculum
Director Endocrinology and Nutrition Department
Navarre headquarters
Status
In recruitment
headquarters
Pamplona/Madrid

Technical Summary

  • PRECISION MEDICINE AGAINST DIABETES TYPE 2: GENETIC PREDICTION AND NUTRITIONAL INTERVENTION WITH MICROBIOTA MODULATING POSTBIOTICS.
  • Code EudraCT: 00
  • Protocol number: Diabet2Predict
  • Promoter: GEMBIOMA

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION